CIK 0000811641
- Non-accelerated filer
- Smaller reporting company
IMMUCELL CORP /DE/
Sign in to watch- Ticker
- ICCC
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010382980
- Phone
- +1 207-878-2770
- Business address
- 56 EVERGREEN DR, PORTLAND, ME, 04103
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 15,000 shares at $5.80 ($87,000)
- 4 Open-market buy Director bought 1,873 shares at an average $6.63 ($12,410)
- 4 Open-market buy Director bought 2,322 shares at an average $6.24 ($14,497)
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy Director bought 10 shares
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 3,200 shares at an average $3.46 ($11,084)
- 4 Open-market buy Director bought 1,420 shares at an average $3.17 ($4,508)
- 4 Open-market buy Director bought 200 shares at $3.00 ($600)
- 4 Open-market buy President & CEO bought 1,000 shares at $2.00 ($2,000)
- 4 Open-market buy Vice President & CSO bought 1,000 shares at $2.00 ($2,000)
- 4 Open-market buy Director bought 5,000 shares at $3.00 ($15,000)
- 4 Open-market buy Director bought 200 shares at $3.00 ($600)
- 4 Open-market buy Director bought 200 shares at an average $3.10 ($620)
- 4 Open-market buy Director bought 900 shares at an average $3.33 ($2,999)
- 4 Open-market buy Director bought 2,480 shares at an average $3.53 ($8,752)
- 4/A Other acquisition Director acquired 89 shares (other)
- 4 Open-market buy Director bought 1,000 shares at $3.79 ($3,793)
- 4 Open-market buy Director bought 1,200 shares at $3.70 ($4,440)
Page 8 of 13 · 256 filings